30.04.2013 Views

2007, Piran, Slovenia

2007, Piran, Slovenia

2007, Piran, Slovenia

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Environmental Ergonomics XII<br />

Igor B. Mekjavic, Stelios N. Kounalakis & Nigel A.S. Taylor (Eds.), © BIOMED, Ljubljana <strong>2007</strong><br />

90<br />

ALTITUDE ATTENUATES APNEA-INDUCED INCREASE IN<br />

HAEMOGLOBIN CONCENTRATION<br />

Matt Richardson and Erika Schagatay<br />

Environmental Physiology Group, Mid-Sweden University, Sundsvall, Sweden<br />

Contact person: matt.richardson@miun.se<br />

INTRODUCTION<br />

During apnea at sea-level, a contraction of the spleen occurs in humans (Hurford et al<br />

1990) causing a transient increase in hemoglobin concentration (Hb) and hematocrit<br />

(Schagatay et al 2001). The development of these increases is progressive across 3<br />

serial apneas, typically resulting in Hb increases of 2% (Richardson et al, 2003), and<br />

recovery to pre-apneic values within 8-9 minutes (Schagatay et al 2005). The spleen<br />

contraction-associated Hb increase is in part triggered by the hypoxia occurring<br />

during apnea (Richardson et al 2005). The Hb increase leads to increased blood gas<br />

storage capacity which facilitates prolonged apnea in humans and may be responsible<br />

for the known prolongation of serial apneas (Schagatay et al 2001). At altitude, we<br />

suggest that the chronic hypoxia could induce splenic contraction during eupnea in<br />

humans, as previously observed in mice (Cook and Alafi 1956). Our aim was to<br />

reveal whether spleen related Hb increase occurs during eupneic altitude exposure in<br />

humans, thereby abolishing the Hb increase normally seen during apnea.<br />

METHODS<br />

This pilot study was conducted during an expedition to the Khumbu region in Nepal,<br />

during which three male subjects performed 3 maximal apneas spaced by 2 minutes<br />

rest at 1230m, 3840m, and 5100m above sea level. Apneas were performed both<br />

during ascent and descent, each of which occurred over a period of two weeks during<br />

the five-week expedition. Blood samples were obtained from the antecubital vein 2<br />

minutes before the apneas (baseline), immediately following apneas (post-apnea) and<br />

10 minutes after the final apnea (recovery), and analyzed via portable Hb analysis unit<br />

(Hemocue, Ängelholm, Sweden). Urine flow was clear to pale yellow immediately<br />

before each sampling session, as a gross estimate of euhydration. Apneic duration,<br />

arterial oxygen saturation (SaO2) during eupnea and the nadir SaO2 resulting from<br />

apnea were also recorded using a stopwatch and a portable oxygen saturation monitor<br />

(Nonin Onyx, Nonin Medical, Minnesota USA), respectively.<br />

RESULTS<br />

At 1230m, SaO2 was 97%, baseline Hb was 143 g/L, SaO2 nadir after apnea was<br />

93% and the post-apnea Hb increase from baseline was 4 g/L. As altitude increased,<br />

baseline SaO2 decreased, baseline Hb values increased, while post-apnea changes in<br />

Hb from baseline were smaller (Figure 1). At 5100m, SaO2 was 78%, baseline Hb<br />

values were 181 g/L, SaO2 nadir was 74% and post-apnea Hb increases had<br />

disappeared. This trend was reversed upon descent, and at 1230m post-apnea the<br />

change from baseline (151g/L) was increased (6 g/L; Figure 1). Mean apneic duration<br />

for the three apneas was negatively correlated to altitude, although mean durations<br />

were longer during the descent trials when compared to the ascent trials (Figure 2).<br />

An apneic duration increase across the 3-apnea series was observed at the lower<br />

altitudes, both during ascent and descent, but at the highest altitude no increase within<br />

the series was noted.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!